IMGT®, the international ImMunoGeneTics information system®

MP Lefranc, V Giudicelli, C Ginestoux… - Nucleic acids …, 2009 - academic.oup.com
MP Lefranc, V Giudicelli, C Ginestoux, J Jabado-Michaloud, G Folch, F Bellahcene, Y Wu…
Nucleic acids research, 2009academic.oup.com
IMGT®, the international ImMunoGeneTics information system®(http://www. imgt. org), was
created in 1989 by Marie-Paule Lefranc, Laboratoire d'ImmunoGénétique Moléculaire LIGM
(Université Montpellier 2 and CNRS) at Montpellier, France, in order to standardize and
manage the complexity of immunogenetics data. The building of a unique ontology, IMGT-
ONTOLOGY, has made IMGT® the global reference in immunogenetics and
immunoinformatics. IMGT® is a high-quality integrated knowledge resource specialized in …
Abstract
IMGT®, the international ImMunoGeneTics information system® (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc, Laboratoire d'ImmunoGénétique Moléculaire LIGM (Université Montpellier 2 and CNRS) at Montpellier, France, in order to standardize and manage the complexity of immunogenetics data. The building of a unique ontology, IMGT-ONTOLOGY, has made IMGT® the global reference in immunogenetics and immunoinformatics. IMGT® is a high-quality integrated knowledge resource specialized in the immunoglobulins or antibodies, T cell receptors, major histocompatibility complex, of human and other vertebrate species, proteins of the IgSF and MhcSF, and related proteins of the immune systems of any species. IMGT® provides a common access to standardized data from genome, proteome, genetics and 3D structures. IMGT® consists of five databases (IMGT/LIGM-DB, IMGT/GENE-DB, IMGT/3Dstructure-DB, etc.), fifteen interactive online tools for sequence, genome and 3D structure analysis, and more than 10 000 HTML pages of synthesis and knowledge. IMGT® is used in medical research (autoimmune diseases, infectious diseases, AIDS, leukemias, lymphomas and myelomas), veterinary research, biotechnology related to antibody engineering (phage displays, combinatorial libraries, chimeric, humanized and human antibodies), diagnostics (clonalities, detection and follow-up of residual diseases) and therapeutical approaches (graft, immunotherapy, vaccinology). IMGT is freely available at http://www.imgt.org.
Oxford University Press